Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
- FHD-909 ( LY4050784 ) advancing in an ongoing Phase 1 trial in SMARCA4 ( BRG1 ) mutated cancers, with non-small cell lung cancer ( NSCLC ) as the primary target population ...
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 - ITeos Therapeutics ( NASDAQ:ITOS )
WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025 ( GLOBE NEWSWIRE ) -- iTeos Therapeutics, Inc.
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025 ( GLOBE NEWSWIRE ) -- iTeos Therapeutics, Inc. ( Nasdaq: ITOS ) , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the ...
GameStop Adds Bitcoin as 'Treasury Reserve Asset'
GME ended the day having lost 0.82%, but has gained 6.3% in after-hours trading after the Bitcoin news was announced.
True North Mortgage Welcomes 25+ Former Rocket Mortgage Canada Employees, Expands Windsor and Quebec Presence
CALGARY, Alberta, March 25, 2025 ( GLOBE NEWSWIRE ) -- True North Mortgage, one of Canada's largest mortgage brokerages, today announced the strategic hiring of over 25 former Rocket Mortgage Canada employees. This move significantly bolsters its team and reinforces its commitment to the Canadian ...
Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research ( AACR ) Annual Meeting 2025 - Zentalis Pharma ( NASDAQ:ZNTL )
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in patients with high-grade serous ovarian cancer ( HGSOC )
Freddie Mac Issues Monthly Volume Summary for February 2025
MCLEAN, Va., March 25, 2025 ( GLOBE NEWSWIRE ) -- Freddie Mac ( OTCQB: FMCC ) today posted to its website its Monthly Volume Summary for February 2025, which provides information on Freddie Mac's mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities ...
Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research ( AACR ) Annual Meeting 2025
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in patients with high-grade serous ovarian cancer ...
Major Credit Card Provider Warns US Consumers Are Spending Less - Synchrony Financial ( NYSE:SYF )
Synchrony Financial's chief credit officer tells Reuters that consumer spending has decreased across income levels. Pelosi's latest AI pick skyrocketed 169% in just one month. Click here to discover the next stock our government trade tracker is spotlighting-before it takes off.
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
TORONTO, March 25, 2025 ( GLOBE NEWSWIRE ) -- Blueberries Medical Corp. ( CSE: BBM ) ( OTC: BBRRF ) ( FRA: 1OA ) ( the "Company" or "Blueberries" ) , a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement ...